These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 6562014)

  • 1. [Therapy of exocrine pancreatic insufficiency].
    Lankisch PG; Lembcke B
    Dtsch Med Wochenschr; 1984 May; 109(18):720-2. PubMed ID: 6562014
    [No Abstract]   [Full Text] [Related]  

  • 2. Controversies in the treatment of exocrine pancreatic insufficiency.
    DiMagno EP
    Dig Dis Sci; 1982 Jun; 27(6):481-4. PubMed ID: 6919479
    [No Abstract]   [Full Text] [Related]  

  • 3. Therapy of pancreatogenic steatorrhoea: does acid protection of pancreatic enzymes offer any advantage?
    Lankisch PG; Lembcke B; Göke B; Creutzfeldt W
    Z Gastroenterol; 1986 Dec; 24(12):753-7. PubMed ID: 3548109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of diet on exocrine pancreatic insufficiency in dogs.
    Pidgeon G
    J Am Vet Med Assoc; 1982 Aug; 181(3):232-5. PubMed ID: 6921199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Therapy of pancreatogenic steatorrhea. Comparison of 2 acid-protected enzyme preparations].
    Lankisch PG; Lembcke B; Kirchhoff S; Hilgers R; Creutzfeldt W
    Dtsch Med Wochenschr; 1988 Jan; 113(1):15-7. PubMed ID: 3335192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [PANCREATIC EXOCRINE INSUFFICIENCY AND ITS CORRECTION IN CHILDREN WITH TYPE I DIABETES IN COMBINATION WITH CELIAC DISEASE].
    Bolshova EV; Lukashuk IV; Lukashuk VD
    Lik Sprava; 2015; (1-2):167-9. PubMed ID: 26118067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of steatorrhea in chronic pancreatitis.
    Graham DY
    Hosp Pract (Off Ed); 1986 Jan; 21(1):125-9. PubMed ID: 3080447
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparative effects of antacids, cimetidine and enteric coating on the therapeutic response to oral enzymes in severe pancreatic insufficiency.
    Regan PT; Malagelada JR; DiMagno EP; Glanzman SL; Go VL
    N Engl J Med; 1977 Oct; 297(16):854-8. PubMed ID: 20572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pancreatic enzyme replacement: the effect of antacids or cimetidine.
    Graham DY
    Dig Dis Sci; 1982 Jun; 27(6):485-90. PubMed ID: 6282548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Replacement therapy in pancreatic insufficiency with a new pancreatin preparation respecting the physiological ratio of lipase/trypsin activity.
    Pap A; Varró V
    Hepatogastroenterology; 1988 Apr; 35(2):83-6. PubMed ID: 3371850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Therapy of digestive insufficiency in cystic fibrosis].
    Auricchio S
    Pediatria (Napoli); 1981 Sep; 89(3):305-14. PubMed ID: 7050880
    [No Abstract]   [Full Text] [Related]  

  • 12. Properties of different pancreatin preparations used in pancreatic exocrine insufficiency.
    Piehl S; Brinkmann R; Windeck T
    Eur J Gastroenterol Hepatol; 2010 May; 22(5):635-6; author reply 636-7. PubMed ID: 20393298
    [No Abstract]   [Full Text] [Related]  

  • 13. [Syndrome after resecting interventions on the pancreas (including drainage operations)].
    Siewert R; Lankisch PG
    Z Gastroenterol Verh; 1982 Apr; 17():38-49. PubMed ID: 6191458
    [No Abstract]   [Full Text] [Related]  

  • 14. Raised fecal fat concentration is not a valid indicator of pancreatic steatorrhea.
    Lembcke B; Grimm K; Lankisch PG
    Am J Gastroenterol; 1987 Jun; 82(6):526-31. PubMed ID: 3646827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical and pharmacological aspects of pancreatic enzyme substitution therapy].
    Löser C; Fölsch UR
    Leber Magen Darm; 1991 Mar; 21(2):56, 59-62, 65. PubMed ID: 1710011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response to: properties of different pancreatin preparations used in pancreatic exocrine insufficiency, Löhr JM et al. Eur J Gastroenterol Hepatol 2009; 21(9):1024-1031.
    Lederer PC
    Eur J Gastroenterol Hepatol; 2010 May; 22(5):635; author reply 636-7. PubMed ID: 20393299
    [No Abstract]   [Full Text] [Related]  

  • 17. [Multicenter comparative study of a new formulation of pancreatin in gastro-resistant microgranules for the treatment of exocrine pancreatic insufficiency in children with mucoviscidosis].
    Duhamel JF; Vidailhet M; Le Luyer B; Douchain F; Jehanne M; Clavel R; Guillot M
    Ann Pediatr (Paris); 1988 Jan; 35(1):69-74. PubMed ID: 3284429
    [No Abstract]   [Full Text] [Related]  

  • 18. Adequate enzymatic substitution in treating exocrine pancreatic insufficiency.
    Simek I; Kubias K; Duda M
    Acta Physiol Hung; 1992; 80(1-4):417-21. PubMed ID: 1364280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Canine exocrine pancreatic insufficiency treated with porcine pancreatic extract.
    Kim JW; Jung DI; Kang BT; Kim HJ; Park C; Park EH; Lim CY; Park HM
    J Vet Sci; 2005 Sep; 6(3):263-6. PubMed ID: 16131834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enzyme treatment of exocrine pancreatic insufficiency in chronic pancreatitis.
    Lankisch PG
    Digestion; 1993; 54 Suppl 2():21-9. PubMed ID: 8224569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.